Lanxess

Topics • Strategy

Climate-friendly Production

News

Slowly But Surely: Short-Interviews with Hans Wijers, Steven Sterin, Patrick Jany, Curt Espeland, Klaus Engel and Axel Heitmann

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Interview

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Lanxess

Lanxess in Talks to Buy Rubber Group Eliokem

Lanxess: New Jhagadia Site Up and Running

Lanxess Named 'Supplier of the Year'

Lanxess to Build New Formalin Facility At Its Krefeld-Uerdingen Site

Lanxess Acquires PTAP Product Line

Lanxess Divests Sites; Heitmann ‘Optimistic’ for 2010

Climate-friendly Production

Slowly But Surely: Short-Interviews with Hans Wijers, Steven Sterin, Patrick Jany, Curt Espeland, Klaus Engel and Axel Heitmann

Top-Feature

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Upcoming Virtual Events

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Siemens Joins the Global Impact Coalition

Interview

Navigating Uncertainty and Driving Innovation

Lanxess

Top-Feature

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Upcoming Virtual Events

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Siemens Joins the Global Impact Coalition

Interview

Newsletter & e-edition